Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Due to system maintenance, login and edit functionaility is currently unavailable

Edward L. Giovannucci, D.Sc., M.D.

Co-Author

This page shows the publications co-authored by Edward Giovannucci and Danny Milner.
Connection Strength

0.631
  1. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. 2016 07; 27(4):602-11.
    View in: PubMed
    Score: 0.167
  2. Ogino et Al. Respond to "the 21st century epidemiologist". Am J Epidemiol. 2012 Oct 15; 176(8):672-4.
    View in: PubMed
    Score: 0.128
  3. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol. 2012 Oct 15; 176(8):659-67.
    View in: PubMed
    Score: 0.128
  4. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. 2018 06; 67(6):1168-1180.
    View in: PubMed
    Score: 0.047
  5. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol. 2016 Nov 03; 7(11):e200.
    View in: PubMed
    Score: 0.043
  6. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn. 2016; 16(1):11-23.
    View in: PubMed
    Score: 0.040
  7. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016 12; 65(12):1973-1980.
    View in: PubMed
    Score: 0.039
  8. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol. 2015 Aug; 1(5):653-61.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.